对阿尔波特综合征的mRNA疗法
bioRxiv : the preprint server for biology
|February 6, 2026
概括
mRNA疗法为阿尔波特综合征提供了一个有前途的新疗法,阿尔波特综合征是一种遗传性病. 这种疗法使用脂质纳米颗粒传递遗传物质,成功地减少了小鼠模型中的症状.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 阿尔波特综合征是一种遗传性脏疾病,由IV型原体基因的突变引起.
- 目前的治疗方法可以控制症状,但不能解决潜在的遗传缺陷,导致功能衰竭.
研究的目的:
- 研究mRNA治疗治疗X链接阿尔波特综合征 (XLAS) 的疗效.
- 确定脂质纳米粒子 (LNP) 传递的mRNA是否可以恢复IV原蛋白的产生,并阻止疾病的进展.
主要方法:
- 在XLAS的小鼠中,静脉注射了含有COL4A3,COL4A4和COL4A5.5的mRNA的LNP.
- 通过测量蛋白尿和血液尿素水平来评估治疗效果.
主要成果:
- 在XLAS小鼠中,mRNA治疗显著降低了蛋白尿和血尿素.
- 随着持续的LNP-mRNA注射,治疗效益保持不变,但在终止后就会失去.
结论:
- 基因mRNA疗法证明了在小鼠模型中治疗阿尔波特综合征的原理证明.
- 脏过屏障损伤可以用于针对性地向脏细胞输送大分子疗法.
更多相关视频
相关概念视频
Regulated mRNA Transport
7.0K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
7.0K
pre-mRNA Processing
57.6K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
57.6K
Nuclear Export of mRNA
8.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
8.8K
Nuclear Export of mRNA
5.5K
5.5K
mRNA Stability and Gene Expression
6.7K
The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
Cis-acting Elements involved in mRNA stability
6.7K
Nonsense-mediated mRNA Decay
11.9K
The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
11.9K


